December 19, 2013
Researchers at the University of California, San Diego School of Medicine, with colleagues in The Netherlands and United Kingdom, have produced the first map detailing the network of genetic interactions underlying the cellular response to ultraviolet (UV) radiation.
October 17, 2019
New Precision Immunotherapy Therapy clinic at Moores Cancer Center at UC San Diego Health matches patients using genetic profiling to personalized cancer treatment plans.
March 20, 2013
On March 19, the National Comprehensive Cancer Network® announced the election of University of California, San Diego Moores Cancer Center as the first and only San Diego-based NCCN Member Institution dedicated to improving the quality, effectiveness, and efficiency of care provided to patients with cancer.
February 6, 2020
Researchers from University of California San Diego School of Medicine have defined the most detailed list of genetic fingerprints of DNA-damaging processes that drive cancer development to date.
October 10, 2013
Researchers at the University of California, San Diego School of Medicine have isolated and characterized the progenitor cells that eventually give rise to malignant hepatocellular carcinoma tumors – the most common form of liver cancer. The researchers found ways to identify and isolate the HCC progenitor cells long before actual…
January 26, 2021
Viral infections and space travel similarly trigger inflammation and the enzymes APOBEC3C and ADAR1; UC San Diego researchers are developing ways to inhibit them as a means to potentially lower cancer risk for both astronauts and people on Earth.
September 25, 2019
Five UC San Diego bioengineering graduate students working at the interface of biology, engineering and health have been honored as 2020 Siebel Scholars.
March 11, 2024
UC San Diego Health provides the most advanced neurological cancer care by combining leading-edge surgical techniques and the latest technology.
April 27, 2022
The cowpea mosaic virus has shown great promise as an experimental cancer immunotherapy for treating and preventing recurrence of various cancers. But just how the virus triggers such a potent anti-cancer immune response has remained a mystery. A new study digs deeper and provides answers.
August 8, 2019
The multiple sclerosis drug teriflunomide, paired with targeted cancer therapy, markedly shrinks patient-derived glioblastomas grown in mice by reaching stem cells at the tumor’s root, according to a new UC San Diego School of Medicine study published in Science Translational Medicine.
